Related Experiment Videos
Esophageal intubation for malignant fistulas
P Spinelli1, F G Cerrai, A Mancini
1Endoscopy Division, National Cancer Institute, Milan, Italy.
Surgical Endoscopy
|January 1, 1991
Summary
Esophageal stents effectively restored oral nutrition in patients with malignant fistulas, improving quality of life. This study found the procedure well-tolerated with minimal complications, enhancing survival outcomes for esophageal cancer patients.
Area of Science:
- Gastroenterology and Endoscopy
- Oncology
- Surgical Innovation
Background:
- Esophageal neoplasms present significant challenges, often leading to malignant fistulas.
- Complications like pneumonia and mediastinitis complicate treatment and reduce patient quality of life.
- Restoring oral nutrition is critical for patient well-being and treatment efficacy.
Purpose of the Study:
- To evaluate the efficacy and safety of endoscopic intubation with prostheses for esophageal neoplasms.
- To assess the impact of prostheses on oral nutrition restoration in patients with malignant fistulas.
- To analyze complication rates and survival outcomes associated with esophageal stent placement.
Main Methods:
- A retrospective analysis of 140 patients undergoing endoscopic intubation for esophageal neoplasms between April 1978 and December 1989.
- Focus on 19 patients with malignant fistulas complicated by pneumonia and/or mediastinitis.
- Inclusion of data on prosthesis tolerance, nutritional status, complications, and survival.
Main Results:
- Esophageal prostheses were well-tolerated, successfully enabling the restoration of oral nutrition.
- The mean survival time for patients was 4.7 months (range: 0.5-17 months).
- No major complications were reported; tube dislodgement occurred in 10.5% of cases (2 patients).
Conclusions:
- Endoscopic intubation with prostheses is a safe and effective treatment for esophageal neoplasms complicated by malignant fistulas.
- The procedure significantly improves the quality of life by restoring oral nutrition.
- Low complication rates and manageable side effects support its use in palliative care.